Polydextrose

Also called PDX, Litesse, polydextrose fiber, soluble fiber polydextrose.

The short answer

From 11 sources

Constipation trials disagree. In 192 adults, 12 g a day raised bowel movements, but in 128 adults 8 to 12 g a day did not speed transit or raise stool frequency. Small trials found bulkier, softer stools and less food eaten at the next meal. Polydextrose did not lower after-meal blood sugar in a 53-person test.

Key facts

What it is
A glucose polymer that resists digestion and is fermented in the colon83
Constipation (two trials)
More bowel movements at 12 g a day in 192 adults; no change in transit or frequency in 128 adults23
Stool bulk (36 adults)
20 g a day raised fecal weight and stool frequency and softened stools vs low-fiber control5
Appetite (21 adults)
Lunch energy intake fell with each dose: 5,756 kJ at 0 g vs 4,362 kJ at 25 g6
Doses tested
4 to 25 g a day26

What it is

Polydextrose is a synthetic soluble fiber made from glucose, added to foods and fiber supplements; most of it is not digested.

How it works

Established

Undigested polydextrose reaches the colon, where it is fermented; trials found higher fecal weight and lower fecal pH, consistent with a bulking, fermentable fiber.5

Forms

Form

The form on this page
FormElemental %Absorption (human data)GI toleranceStudied for
Polydextrose powder or fiber-fortified foodsVaries25Not applicable (a fiber dosed in grams)Mostly not digested; fermented in the colon, lowering fecal pH.5Well tolerated at 8 to 16 g; 20 g a day brought more gas and gut noises than a low-fiber control.85Constipation, stool bulk, appetite

What the human research says

Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.

Trial map

10 graded outcomes, largest study first

10 graded outcomes: 5 improved, 3 mixed, 2 no effect. The largest, a 2019 randomized trial of 192 people on colonic transit and bowel movements in functional constipation, found mixed results. Outcomes that improved came from smaller studies: a median of 28 people, against 91 for no effect.

1Colonic transit and bowel movements in functional constipation

Mixed · Grade C · RCT, 192 people, 2019

Adults with functional constipation (Rome III), who turned out only mildly constipated

Dose, result and source
Every graded outcome on this page, largest study first
OutcomeFoundPeopleStudyWho was studied
Colonic transit and bowel movements in functional constipationMixed192Grade C · RCT, 2019Adults with functional constipation (Rome III), who turned out only mildly constipated
Transit time and stool frequency in chronic constipationNo effect128No-effect grade · RCT, 2018Adults with chronic constipation
Stool consistency and bowel movements in functional constipationMixed97Grade D · RCT, 2023Chinese adults with functional constipation
After-meal blood sugar and insulinNo effect53No-effect grade · Crossover RCT, 2017Healthy adults (34 beverage study, 19 bar study)
Stool frequency in hemodialysis patients on laxativesImproved50Grade C · RCT, 2015Japanese hemodialysis outpatients aged 51 to 79 using laxatives
Fecal weight, stool frequency and softnessImproved36Grade D · Crossover RCT, 2013Healthy men and women in the US
Constipation symptoms in hemodialysis patientsImproved28Grade D · RCT, 2023Hemodialysis patients in Brazil (25 completed: 16 polydextrose, 9 control)
Food eaten at the next mealImproved21Grade D · Crossover RCT, 2013Healthy adults (12 men, 9 women) in the UK
Cognitive flexibility and sustained attentionImproved18Grade D · Crossover RCT, 2021Healthy women
Fat burning, blood sugar and appetiteMixed18Grade D · Crossover RCT, 2014Overweight men and women in the Netherlands
Each circle is one graded outcome on this page, numbered from the largest study down, and placed by how many people it studied (log scale). It shows who was studied and what was found, not advice about your dose.

Every graded row

10 rows

Showing 10 of 10 outcomes. Human trials only.

Grade CColonic transit and bowel movements in functional constipationConstipationMore bowel movements at 12 gRCT
n 192 · 2019

Mixed Bowel movements rose with 12 g a day; the abstract does not report a benefit on transit time, the primary outcome; symptom inventories improved vs baseline. No serious adverse events.

Design
RCT, n = 192, 2019
Population
Adults with functional constipation (Rome III), who turned out only mildly constipated
Form
Polydextrose (Litesse Ultra)
Dose
4, 8 or 12 g a day
Duration
2 weeks
Source
Reference 2 · PubMed 30791557 (opens PubMed)
Grade CStool frequency in hemodialysis patients on laxativesConstipationMore frequent stoolsRCT
n 50 · 2015

Improved Stool frequency rose from 3.0 to 7.5 times a week (p < 0.01) with no bloating, cramps or diarrhea reported; blood chemistry did not change.

Design
RCT, n = 50, 2015
Population
Japanese hemodialysis outpatients aged 51 to 79 using laxatives
Form
Polydextrose
Dose
10 g a day
Duration
8 weeks
Source
Reference 4 · PubMed 26440643 (opens PubMed)
Grade DStool consistency and bowel movements in functional constipationConstipationSofter stools; frequency unchangedRCT
n 97 · 2023

Mixed Stools became softer within the group (Bristol scale up about 1 point, unchanged on placebo) and the 4-week change beat placebo, but the main time-by-group test found no difference for stool form, bowel movement frequency or straining. Bifidobacterium rose more than on placebo.

Design
RCT, n = 97, 2023
Population
Chinese adults with functional constipation
Form
Fiber blend: polydextrose with xylo- and fructo-oligosaccharides and resistant dextrin
Dose
3.92 g polydextrose a day (two sachets), plus about 3.9 g oligosaccharides and 1.5 g resistant dextrin
Duration
4 weeks
Source
Reference 10 · PubMed 37078654 (opens PubMed)
Grade DFecal weight, stool frequency and softnessStool bulkBulkier, softer stoolsCrossover RCT
n 36 · 2013

Improved Five-day fecal wet weight, stools per day and fecal output rose and stools were softer (P = 0.002) vs low-fiber control; transit time did not change; more gas and gut noises.

Design
Crossover RCT, n = 36, 2013
Population
Healthy men and women in the US
Form
Polydextrose in muffins and cereal
Dose
20 g a day
Duration
10 days per period
Source
Reference 5 · PubMed 23427334 (opens PubMed)
Grade DConstipation symptoms in hemodialysis patientsConstipationFewer stool symptomsRCT
n 28 · 2023

Improved The fecal-symptom domain (P = .004) and quality-of-life concerns (P = .02) improved after polydextrose; inflammation markers did not change.

Design
RCT, n = 28, 2023
Population
Hemodialysis patients in Brazil (25 completed: 16 polydextrose, 9 control)
Form
Polydextrose
Dose
12 g a day
Duration
2 months
Source
Reference 9 · PubMed 37321430 (opens PubMed)
Grade DFood eaten at the next mealAppetiteAte less at lunchCrossover RCT
n 21 · 2013

Improved Lunch intake fell from 5,756 kJ (0 g) to 5,048, 4,722 and 4,362 kJ with rising doses (P < 0.05) without changes in rated appetite; total daily intake was lower at 12.5 and 25 g.

Design
Crossover RCT, n = 21, 2013
Population
Healthy adults (12 men, 9 women) in the UK
Form
Polydextrose in a liquid preload
Dose
6.3, 12.5 or 25 g once
Duration
Single test days
Source
Reference 6 · PubMed 23340248 (opens PubMed)
Grade DFat burning, blood sugar and appetiteMetabolismLower glucose peak; less appetiteCrossover RCT
n 18 · 2014

Mixed Peak glucose and insulin fell and fat oxidation rose, but mainly because the diet had less energy rather than the fiber itself; appetite ratings were lower.

Design
Crossover RCT, n = 18, 2014
Population
Overweight men and women in the Netherlands
Form
Polydextrose replacing 30% of carbohydrate
Dose
At breakfast and lunch (amount not stated in the abstract)
Duration
24 hours per diet
Source
Reference 7 · PubMed 23880340 (opens PubMed)
Grade DCognitive flexibility and sustained attentionCognitionImprovedCrossover RCT
n 18 · 2021

Improved Fewer errors on a set-shifting task (cognitive flexibility) and better sustained attention than with maltodextrin; microbial diversity did not change.

Design
Crossover RCT, n = 18, 2021
Population
Healthy women
Form
Polydextrose (Litesse Ultra, over 90% polydextrose)
Dose
12.5 g a day
Duration
4 weeks per period
Source
Reference 11 · PubMed 32951067 (opens PubMed)
No effectTransit time and stool frequency in chronic constipationConstipationNo change in transitRCT
n 128 · 2018

No effect No reduction in transit time and no change in stool frequency or consistency; some symptom subscores (rectal, stool) improved at 8 g a day.

Design
RCT, n = 128, 2018
Population
Adults with chronic constipation
Form
Polydextrose
Dose
8 g or 12 g a day
Duration
4 weeks
Source
Reference 3 · PubMed 30029461 (opens PubMed)
No effectAfter-meal blood sugar and insulinBlood sugarNo glucose loweringCrossover RCT
n 53 · 2017

No effect Polydextrose did not lower after-meal glucose or insulin at any dose in either food; it was well tolerated.

Design
Crossover RCT, n = 53, 2017
Population
Healthy adults (34 beverage study, 19 bar study)
Form
Polydextrose in a beverage or bar
Dose
8, 12 or 16 g
Duration
Single test days
Source
Reference 8 · PubMed 28892156 (opens PubMed)

What the numbers add up to

Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.

The two biggest constipation trials disagree

12 g a day raised bowel movements in 192 adults (DuPont-funded), while 8 to 12 g a day changed neither transit nor frequency in 128 adults (Nestlé-funded).23

How we got this: Comparison of the 2019 and 2018 RCTs

It bulks stools more than it speeds them

Fecal weight and softness rose at 20 g a day, but transit time did not change in that trial or the 128-person trial.53

How we got this: Outcomes of the 2013 crossover and the 2018 RCT

Studied doses

Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.

Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Doses studied in human trials

Doses studied in human trials ranged from about 4 g (3.92 g in a fiber blend) to 20 g of polydextrose a day for 10 days to 8 weeks, with single servings up to 25 g in appetite tests.102546

Interactions and safety

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

Interactions

0 agents

None found in our sources.

Check with what you take

Kept on this device only

Add what you take. We list every interaction our evidence profiles cite between Polydextrose and your picks, and between your picks.

Most cited:

Add a supplement or medicine you take to check it against Polydextrose.

Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.

Not medical advice, and no dosing advice. An empty result means no row we cite names that pair, by name or through a drug class we can link the medicine to, not that a combination is safe. Where our sources name only a group of medicines we cannot match, the cabinet says so. Ask your pharmacist before you combine supplements and medicines.

Who should be careful

2 groups
Medicines and surgery
No published drug or supplement interactions for polydextrose were found, and interaction data are limited. NCCIH advises that supplements may interact with medications or pose risks before surgery, and to tell your health care providers about everything you use.1
Pregnancy, breastfeeding and children
LactMed has no entry for polydextrose, and the supplement trials cited here enrolled adults. NCCIH notes that many dietary supplements have not been tested in pregnant women, nursing mothers or children.1
Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

How to read the label

What to check on the Supplement Facts panel.

How to read the label

1 checks
Count the grams of polydextrose

Constipation trials used 8 to 12 g a day of polydextrose alone. Blends that list polydextrose with other fibers in one total do not show how much polydextrose you get.23

Where to buy Polydextrose

Products from brands we partner with that contain Polydextrose. Check the amount per serving against the doses studied above, and the label for other ingredients.

Polydextrose products from partner brands

1 product
  • HerbsProNature's Answer Liquid Fiber, Natural Lemon-Lime, 16 oz

    2 tablespoons (30 mL): 14 g proprietary fiber blend of polydextrose and inulin FOS; the label does not give the polydextrose amount on its own

    $17.29one-timeChecked Oct 15, 2026

Listing a product is not a claim that it works; check the amount per serving against the doses studied, and the label for other ingredients.Prices and labels are from each brand’s own site on the date shown; confirm before you buy.

Partner links may earn us a commission. How partner links work

Frequently asked questions

Short answers to common questions; the numbers link to the sources below.

Common questions

6 answers
Does polydextrose help constipation?

Results conflict: 12 g a day raised bowel movements in 192 adults, but 8 to 12 g a day did not change transit or stool frequency in 128 adults with chronic constipation.23

Does polydextrose lower blood sugar?

No. In tests with 53 adults, 8 to 16 g in a drink or bar did not lower after-meal glucose or insulin.8

Does polydextrose affect thinking or mood?

One exploratory crossover trial in 18 healthy women found 12.5 g a day for 4 weeks slightly improved cognitive flexibility and attention compared with maltodextrin. It has not been repeated (grade D).11

Does polydextrose cause gas?

At 20 g a day, people reported more gas and gut noises than on a low-fiber diet; lower doses were well tolerated in trials.58

How much polydextrose was studied?

Constipation trials used 4 to 12 g a day; a stool-bulk study used 20 g a day, and appetite tests used single servings up to 25 g.256

What is polydextrose?

A soluble fiber made from glucose that mostly escapes digestion and is fermented in the colon. It is added to foods and fiber supplements.85

Sources

11 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.

Sources cited on this page

11 sources
  1. 1Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
  2. 2Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial.RCT Nutrients, 2019 · PMID 30791557
  3. 3Short-Term Daily Intake of Polydextrose Fiber Does Not Shorten Intestinal Transit Time in Constipated Adults: A Randomized Controlled Trial.RCT Nutrients, 2018 · PMID 30029461
  4. 4Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial.RCT J Nutr Sci Vitaminol (Tokyo), 2015 · PMID 26440643
  5. 5Polydextrose and soluble corn fiber increase five-day fecal wet weight in healthy men and women.Crossover RCT J Nutr, 2013 · PMID 23427334
  6. 6Polydextrose results in a dose-dependent reduction in ad libitum energy intake at a subsequent test meal.Crossover RCT Br J Nutr, 2013 · PMID 23340248
  7. 7Effect of polydextrose and soluble maize fibre on energy metabolism, metabolic profile and appetite control in overweight men and women.Crossover RCT Br J Nutr, 2014 · PMID 23880340
  8. 8A Randomized, Controlled Trial Evaluating Polydextrose as a Fiber in a Wet and Dry Matrix on Glycemic Control.Crossover RCT J Food Sci, 2017 · PMID 28892156
  9. 9Effects of Polydextrose Supplementation on Intestinal Function in Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial.RCT J Ren Nutr, 2023 · PMID 37321430
  10. 10Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.RCT Gut Microbes, 2023 · PMID 37078654
  11. 11A specific dietary fibre supplementation improves cognitive performance-an exploratory randomised, placebo-controlled, crossover study.Crossover RCT Psychopharmacology (Berl), 2021 · PMID 32951067

What changed

Every dated change to this page: what changed, who made it and why.

Change log

2 entries
Dated changes to this page
DateChangeWho and why
evidence, studied doses, who should be careful, FAQAdded a 2023 constipation trial of a polydextrose fiber blend (PMID 37078654; group size and dose from the PMC full text) and a 2021 cognition crossover trial (PMID 32951067) as graded rows. Interactions re-checked: no published drug or supplement interactions, and LactMed has no entry; the page now says interaction data are limited. Fact-checked against the sources; corrected: the 2023 constipation trial found no time-by-group difference in stool form either, only a within-group softening and a better 4-week change.Writer: Kymata Health EditorialTrigger: A–Z page audit
allInitial editorial evidence review. Every PMID checked against NCBI E-utilities esummary (title, year, journal; none retracted) and each cited abstract read; numbers taken from the abstracts (full text only for DuPont and Nestec funding). Funding disclosed per study: DuPont Nutrition and Health (2019), Nestec SA (2018), BBSRC (2013 appetite), US FDA (2017 glycemic), CNPq and FAPERJ (2023); other abstracts name no funder (disclosed as not stated). Nulls shown: 2018 transit and frequency, 2017 glycemic response; the 2019 abstract reports no transit benefit. No polydextrose page exists on our approved safety sources, so safety rows use only NCCIH general supplement guidance. Where to buy: Nature's Answer Liquid Fiber (label and price checked 2026-10-15; polydextrose-inulin blend flagged in the serving note).Writer: Kymata Health EditorialTrigger: new page

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.